Additive effect of in-hospital TIMI bleeding and chronic kidney disease on 1-year cardiovascular events in patients with acute coronary syndrome: Data from Taiwan Acute Coronary Syndrome Full Spectrum Registry

Heart and Vessels

Volumn 30, Issue 4, 2015, Pages 441-450

  Lin, Tsung Hsien ^a,b   Lai, Wen Ter ^a,b   Kuo, Chi Tai ^c,d   Hwang, Juey Jen ^e   Chiang, Fu Tien ^e   Chang, Shu Chen ^f   Chang, Chee Jen ^g  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

^g CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Acute coronary syndrome; Bleeding; Chronic kidney disease

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TICLOPIDINE; WARFARIN;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DISEASE REGISTRY; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; IN HOSPITAL BLEEDING; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TAIWAN; THROMBOLYSIS IN MYOCARDIAL INFARCTION; ADVERSE EFFECTS; AGED; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPLICATION; FIBRINOLYTIC THERAPY; HOSPITALIZATION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; RISK FACTOR; STATISTICAL MODEL;

ACUTE CORONARY SYNDROME; AGED; FEMALE; GLOMERULAR FILTRATION RATE; HEMORRHAGE; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TAIWAN; THROMBOLYTIC THERAPY;

EID: 84938417354     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-014-0504-9     Document Type: Article

References (34)

1. Nordlie MA, Wold LE, Kloner RA (2005) Genetic contributors toward increased risk for ischemic heart disease. J Mol Cell Cardiol 39(4):667–679
2. Taiwan Department of Health. Statistics data statistical analysis of 2009 mortality data. Press conference on 2009 mortality data. http://www.doh.gov.tw. Accessed 19 Jan 2011
3. Maréchaux S, Barrailler S, Pinçon C, Decourcelle V, Guidez T, Braun S, Bouabdallaoui N, Bauchart JJ, Auffray JL, Juthier F, Banfi C, Susen S, Jude B, Asseman P, Van Belle E, Ennezat PV (2012) Prognostic value of hemoglobin decline over the GRACE score in patients hospitalized for an acute coronary syndrome. Heart Vessel 27(2):119–127
4. Lindsey JB, Marso SP, Pencina M, Stolker JM, Kennedy KF, Rihal C, Barsness G, Piana RN, Goldberg SL, Cutlip DE, Kleiman NS, Cohen DJ, EVENT Registry Investigators (2009) Prognostic importance of bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients. JACC Interv 2:1074–1082
5. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM, TRITON-TIMI 38 Investigators (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357(20):2001–2015
6. Melloni C, Alexander KP, Chen AY, Newby LK, Roe MT, Allen LaPointe NM, Pollack CV Jr, Gibler WB, Ohman EM, Peterson ED, CRUSADE Investigators (2008) Unfractionated heparin dosing and risk of major bleeding in non-ST-segment elevation acute coronary syndromes. Am Heart J 56(2):209–215
7. Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375(9731):2073–2081
8. Matsue Y, Matsumura A, Abe M, Ono M, Seya M, Nakamura T, Iwatsuka R, Mizukami A, Setoguchi M, Nagahori W, Ohno M, Suzuki M, Hashimoto Y (2013) Prognostic implications of chronic kidney disease and anemia after percutaneous coronary intervention in acute myocardial infarction patients. Heart Vessel 28(1):19–26
9. USRDS (2009) International comparisons. In: United Stated Renal Data System Annual Data Report. The National Institute of health, National Institute of diabetes and digestive and kidney disease. Bethesda, pp 344–355
10. Shyu KG, Wu CJ, Mar GY, Hou Charles JY, Li AH, Wen MS, Lai WT, Lin SJ, Kuo ChT, Hwang JJ, Chiang FT (2011) Clinical characteristics, management and in-hospital outcomes of patients with acute coronary syndrome—observations from the Taiwan ACS Full Spectrum Registry. Acta Cardiol Sin 27:135–144
11. International Epidemiological Association guidelines. http://www.ieaweb.org/index.php?option=com_content&view=article&id=15%3Agood-epidemiological-practice-gep&catid=20%3Agood-epidemiological-practice-gep&Itemid=43&limitstart=1. Accessed 28 Jan 2011
12. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P (1987) Thrombolysis in myocardial infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 76(1):142–154
13. Levey AS, Greene T, Kusek JW (2000) A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11:A0828
14. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39((2 Suppl 1)):S1–S266
15. Valente S, Lazzeri C, Chiostri M, Osmanagaj L, Giglioli C, Gensini GF (2011) STEMI patients–the more you bleed, the more you die: a comparison between classifications. Clin Cardiol 34(2):90–96
16. Rao SV, O’Grady K, Pieper KS, Granger CB, Newby LK, Mahaffey KW, Moliterno DJ, Lincoff AM, Armstrong PW, Van de Werf F, Califf RM, Harrington RA (2006) A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. J Am Coll Cardiol 47(4):809–816
17. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H (2011) Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 123:2736–2747
18. Ndrepepa G, Schuster T, Hadamitzky M, Byrne RA, Mehilli J, Neumann FJ, Richardt G, Schulz S, Laugwitz KL, Massberg S, Schömig A, Kastrati A (2012) Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention. Circulation 125(11):1424–1431
19. Yip HK, Wu CJ, Chang HW, Hsieh YK, Fang CY, Chen SM, Chen MC (2003) Impact of tirofiban on angiographic morphologic features of high-burden thrombus formation during direct percutaneous coronary intervention and short-term outcomes. Chest 124(3):962–968
20. Li YH, Yeh HI, Tsai CT, Liu PY, Lin TH, Wu TC, Hung KC, Hsieh YC, Mar GY, Fang CY, Chiu KM, Chen JH (2012) 2012 Guidelines of the Taiwan Society of Cardiology (TSOC) for the management of ST-Segment Elevation Myocardial Infarction. Acta Cardiol Sin 28:63–89
21. Lopes RD, Subherwal S, Holmes DN, Thomas L, Wang TY, Rao SV, Magnus Ohman E, Roe MT, Peterson ED, Alexander KP (2012) The association of in-hospital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST-segment elevation myocardial infarction. Eur Heart J 33(16):2044–2053
22. Suh JW, Mehran R, Claessen BE, Xu K, Baber U, Dangas G, Parise H, Lansky AJ, Witzenbichler B, Grines CL, Guagliumi G, Kornowski R, Wöhrle J, Dudek D, Weisz G, Stone GW (2011) Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol 58(17):1750–1756
23. Morel O, El Ghannudi S, Jesel L, Radulescu B, Meyer N, Wiesel ML, Caillard S, Campia U, Moulin B, Gachet C, Ohlmann P (2011) Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel. J Am Coll Cardiol 57(4):399–408
24. Keough-Ryan TM, Kiberd BA, Dipchand CS, Cox JL, Rose CL, Thompson KJ, Clase CM (2005) Outcomes of acute coronary syndrome in a large Canadian cohort: impact of chronic renal insufficiency, cardiac interventions, and anemia. Am J Kidney Dis 46:845–855
25. Masoudi FA, Plomondon ME, Magid DJ, Sales A, Rumsfeld JS (2004) Renal insufficiency and mortality from acute coronary syndromes. Am Heart J 147:623–629
26. Baber U, Stone GW, Weisz G, Moreno P, Dangas G, Maehara A, Mintz GS, Cristea E, Fahy M, Xu K, Lansky AJ, Wennerblom B, Mathey DG, Templin B, Zhang Z, Serruys PW, Mehran R (2012) Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes. JACC Cardiovasc Imaging 5(3 Suppl):S53–S61
27. El-Menyar A, Zubaid M, Sulaiman K, Singh R, Al Thani H, Akbar M, Bulbanat B, Al-Hamdan R, Almahmmed W, Al Suwaidi J (2010) In-hospital major clinical outcomes in patients with chronic renal insufficiency presenting with acute coronary syndrome: data from a Registry of 8176 patients. Mayo Clin Proc 85(4):332–340
28. Undas A, Nycz K, Pastuszczak M, Stompor T, Zmudka K (2010) The effect of chronic kidney disease on fibrin clot properties in patients with acute coronary syndrome. Blood Coagul Fibrinolysis 21(6):522–527
29. Mehran R, Pocock SJ, Nikolsky E, Clayton T, Dangas GD, Kirtane AJ, Parise H, Fahy M, Manoukian SV, Feit F, Ohman ME, Witzenbichler B, Guagliumi G, Lansky AJ, Stone GW (2010) A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol 55(23):2556–2566
30. Attallah N, Yassine L, Fisher K, Yee J (2005) Risk of bleeding and restenosis among chronic kidney disease patients undergoing percutaneous coronary intervention. Clin Nephrol 64(6):412–418
31. Fox CS, Muntner P, Chen AY, Alexander KP, Roe MT, Cannon CP, Saucedo JF, Kontos MC, Wiviott SD, Acute Coronary Treatment and Intervention Outcomes Network registry (2010) Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry. Circulation 121(3):357–365
32. Cantor WJ, Mahaffey KW, Huang Z, Das P, Gulba DC, Glezer S, Gallo R, Ducas J, Cohen M, Antman EM, Langer A, Kleiman NS, White HD, Chisholm RJ, Harrington RA, Ferguson JJ, Califf RM, Goodman SG (2007) Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal. Catheter Cardiovasc Interv 69(1):73–83
33. Mehran R, Lansky AJ, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Wong SC, Nikolsky E, Gambone L, Vandertie L, Parise H, Dangas GD, Stone GW, HORIZONS-AMI Trial Investigators (2009) Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet 374(9696):1149–1159
34. Becker RC, Bassand JP, Budaj A, Wojdyla DM, James SK, Cornel JH, French J, Held C, Horrow J, Husted S, Lopez-Sendon J, Lassila R, Mahaffey KW, Storey RF, Harrington RA, Wallentin L (2011) Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial. Eur Heart J 32(23):2933–2944